Webinar: Pharmacovigilance Submissions Simplified: E2B(R3), FAERS & Safety Reporting Explained
The US FDA has announced that E2B(R3) will become mandatory soon, so now is the time to prepare. We are delighted to invite you to join our experts for an exclusive, complimentary, US-focused session. This session will explore key timelines, FAERS implications, and safety database requirements. Secure your spot today and stay compliant!
